This inventor holds 1 USPTO granted patent. Top assignee: Dsm IP Assets B.v.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovations of Hans-Peter Hohnmann
Introduction
Hans-Peter Hohnmann is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of modified enzymes. His work has implications for various applications, including the production of essential vitamins.
Latest Patents
Hohnmann holds a patent for "Mutant GTP cyclohydrolase II enzymes." This invention relates to modified GTP cyclohydrolase II enzymes that display increased specific activity. The patent also covers polynucleotides encoding these enzymes, vectors comprising these polynucleotides, and host cells containing such vectors. Furthermore, the invention provides methods for producing the modified enzyme and for producing riboflavin, a riboflavin precursor, FMN, FAD, or derivatives thereof. He has 1 patent to his name.
Career Highlights
Hohnmann is associated with Dsm IP Assets B.V., where he continues to innovate in the field of enzyme technology. His work has been instrumental in advancing the understanding and application of biocatalysts in industrial processes.
Collaborations
He has collaborated with notable colleagues such as Martin Lehmann and Nigel John Mouncey, contributing to a dynamic research environment that fosters innovation.
Conclusion
Hans-Peter Hohnmann's contributions to enzyme technology and his innovative patents highlight his role as a significant figure in the field of biochemistry. His work continues to influence the production of vital compounds, showcasing the importance of innovation in science.